In an exclusive interview with Moneycontrol, Dr Reddy's CFO, M.V. Narasimham highlighted the company's plans on moving up the ...

He won’t give timelines about development of the drugs with Sanofi, which is still deciding ... on topics including regulation, mergers and acquisitions, and the latest clinical developments.

Based on previous success rates of ∼20%—and on typical development timelines of seven to eight ... such as Paris-based Sanofi-aventis, GlaxoSmithKline (GSK), Merck and Wyeth, of Madison ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...

Crossmark Global Holdings Inc. increased its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 23.7% during the ...

The acquisition of global rights to NJO from Sanofi is expected to contribute positively to EBITDA from 2025 onwards. Recordati SpA (RICFY) reported a robust free cash flow of 434.3 million euros, up ...

Signing Day Sports, Inc. ( (SGN) ) has issued an update. Signing Day Sports has extended its timeline to acquire Dear Cashmere Group, doing business as Swifty Global, to November 22, 2024 ...

Sanofi has added to its rare disease pipeline by licensing an antibody-RNA conjugate (ARC) for facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder, from US biotech miRecule.

This new office will serve as a central hub for managing its latest acquisitions ... 150 acres of plotted land within the promised timelines and has another 700 acres under development, across ...

The company’s brokers, Barrenjoey Capital Partners and Unified Capital Partners, have split the cash call into a $60.5 million placement and a $6 million share purchase plan. Advent Partners ...